The new radiotracer flurpiridaz is poised to make a major impact on nuclear cardiology. Timothy Bateman, MD, co-director of the cardiovascular radiologic imaging program at Saint Luke's Mid America Heart Institute, shared details on the tracer in a new interview. 

The popular AI chatbot got most of the answers it was asked by researchers right, but its reliability is still up in the air.

Scientists believe this is the first series demonstrating a significant survival difference in patients monitored with an intensive follow-up strategy via 18F-fludeoxyglucose–positron emission tomography.  

Given the approach’s “superior prognostic value,” experts urged for the incorporation of tau PET into routine clinical evaluation in memory care clinics. 

New research, presented at SNMMI 2023, details how the brains of obese individuals differ from those who maintain a healthy weight.  

This year the Henry N. Wagner Jr., Image of the Year is actually a group of images displaying the efficacy of a 68Ga-DOTA-5G and 177Lu-DOTA-ABM-5G theranostic pairing that improves the detection and treatment of metastatic pancreatic cancer. 

The new technology achieves this by way of two add-on detectors that simultaneously scan patients during their whole-body PET exam.

Posluma (flotufolastat F 18) received the U.S. Food and Drug Administration’s approval in May 2023.